Condition

Familial Amyloidosis, Finnish Type

Endocrine, Nutritional and Metabolic Diseases

Familial amyloidosis, Finnish type, also called hereditary gelsolin amyloidosis or AGel amyloidosis, is an amyloid condition with a number of associated cutaneous and neurological presentations. It arises from the aberrant proteolysis of a mutated form of plasma gelsolin, and the mutations are inherited in an autosomal dominant fashion. It was first described in 1969 by the Finnish ophthalmologist Jouko Meretoja. The condition is uncommon, with roughly 400 to 600 cases described in Finland and about 15 elsewhere. This entry records how the condition is classified and described, and is not medical advice.

Facts
Classification
Body System
Integumentary System 1
Body System
Nervous System 1
ICD-10 Chapter
IV: Endocrine, Nutritional and Metabolic Diseases 1
Communicable or Non-communicable
Non-Communicable 1
First Described
1969 1
Prevalence Band
Rare (Under 1 in 2000) 2
Causative Agent
Causative Agent (category)
Genetic / Hereditary 1
Sources
1. Familial Amyloidosis, Finnish Type (Wikipedia)
  • Lead paragraph
    First described in 1969 by the Finnish ophthalmologist Jouko Meretoja
  • Lead paragraph [causative-agent-category]
    Mutations are inherited in an autosomal dominant fashion.
  • Lead paragraph [body-system]
    a number of associated cutaneous and neurological presentations
  • lead sentence 1
    Familial Amyloidosis, Finnish Type (FAF), also called hereditary gelsolin amyloidosis and AGel amyloidosis (AGel), is an amyloid condition with a number of associated cutaneous and neurological presentations deriving from the aberrant proteolysis of a mutated form of plasma gelsolin.
  • Lead: disease category
    Familial Amyloidosis, Finnish Type (FAF), also called hereditary gelsolin amyloidosis and AGel amyloidosis (AGel), is an amyloid condition with a number of associated cutaneous and neurological presentations deriving from the aberrant proteolysis of a mutated form of plasma gelsolin.
View the Source
2. Orphadata (Orphanet): Orphadata epidemiology for ORPHA:85448 AGel amyloidosis
Orphadata (Orphanet)Prevalence, Worldwide
Quote, Prevalence, Worldwide
"PrevalenceClass": "\u003c1 / 1 000 000", "PrevalenceGeographic": "Worldwide"
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.

Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme